- Home
- TLPH vs IMCC Comparison
TLPH vs IMCC Comparison
Compare TLPH & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- IMCC
- Stock Information
- Founded
- TLPH 2005
- IMCC 1980
- Country
- TLPH United States
- IMCC Israel
- Employees
- TLPH N/A
- IMCC N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- TLPH Health Care
- IMCC Health Care
- Exchange
- TLPH Nasdaq
- IMCC Nasdaq
- Market Cap
- TLPH 10.6M
- IMCC 11.8M
- IPO Year
- TLPH 2011
- IMCC N/A
- Fundamental
- Price
- TLPH $0.42
- IMCC $2.56
- Analyst Decision
- TLPH Strong Buy
- IMCC
- Analyst Count
- TLPH 1
- IMCC 0
- Target Price
- TLPH $6.00
- IMCC N/A
- AVG Volume (30 Days)
- TLPH 148.3K
- IMCC 50.5K
- Earning Date
- TLPH 08-14-2025
- IMCC 08-12-2025
- Dividend Yield
- TLPH N/A
- IMCC N/A
- EPS Growth
- TLPH N/A
- IMCC N/A
- EPS
- TLPH N/A
- IMCC N/A
- Revenue
- TLPH $27,000.00
- IMCC $38,430,631.00
- Revenue This Year
- TLPH N/A
- IMCC $47.12
- Revenue Next Year
- TLPH $14,533.26
- IMCC $12.83
- P/E Ratio
- TLPH N/A
- IMCC N/A
- Revenue Growth
- TLPH N/A
- IMCC 5.08
- 52 Week Low
- TLPH $0.38
- IMCC $1.29
- 52 Week High
- TLPH $1.19
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- TLPH 49.00
- IMCC 45.77
- Support Level
- TLPH $0.39
- IMCC $2.52
- Resistance Level
- TLPH $0.46
- IMCC $3.13
- Average True Range (ATR)
- TLPH 0.02
- IMCC 0.33
- MACD
- TLPH 0.00
- IMCC -0.00
- Stochastic Oscillator
- TLPH 58.83
- IMCC 29.87
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.